三星電子(Samsung Electronics)首席策略官孫英權(quán)(Young Sohn)正率領(lǐng)公司投入數(shù)字醫(yī)療革命，著手為相關(guān)設(shè)備與應(yīng)用程序打造一個(gè)平臺(tái)，讓消費(fèi)者能管理自己的健身、甚至是醫(yī)療照護(hù)信息；其他很多公司也同樣期望推動(dòng)醫(yī)療革命，但很少有像三星這樣，是由最高層主管親自領(lǐng)軍。 孫英權(quán)透露，將在該公司于今年秋天在美國(guó)舊金山舉行的開發(fā)者大會(huì)上，發(fā)表名為 Simband 的開放性平臺(tái)硬件接口規(guī)格；該平臺(tái)專供智能腕帶使用，可容納各種健身與醫(yī)療傳感器。同時(shí)該場(chǎng)開發(fā)者大會(huì)也將發(fā)表專為Simband平臺(tái)撰寫軟件程序與云端 服務(wù)的軟件接口規(guī)格。目前Simband的初期版本已經(jīng)提供給大約十家軟件開發(fā)商，主要是新創(chuàng)公司；孫東權(quán)也打算親自拜訪歐洲的Bosch等傳感器大廠， 洽談合作事宜。 在一場(chǎng)于比利時(shí)舉行的年度IMEC科技論壇上，孫英權(quán)表示：“這整個(gè)領(lǐng)域仍然在非常早期的階段，許多新創(chuàng)公司需要一個(gè)平臺(tái)，因此我們的目標(biāo)是讓50~100家公司能加入這個(gè)平臺(tái)?！比亲约阂矊⒃谇锾斓拈_發(fā)者大會(huì)上推出自己的試用版產(chǎn)品，正式商用版則預(yù)計(jì)在明年上市；此外該公司打算投入5,000萬美元資金，扶植為新平臺(tái)開發(fā)傳感器或軟件的新創(chuàng)公司。 到目前為止，三星已經(jīng)宣布了兩項(xiàng)策略合作案：其一是美國(guó)舊金山大學(xué)(University of San Francisco)將協(xié)助該公司驗(yàn)證傳感器，應(yīng)該是采用該校醫(yī)學(xué)院的設(shè)備；其二是歐洲研究機(jī)構(gòu)IMEC成為三星在開發(fā)可量測(cè)心電圖、生物阻抗(bio- impedance)、皮膚溫度、加速度等數(shù)據(jù)之多功能感測(cè)設(shè)備的第一個(gè)合作伙伴。孫東權(quán)表示：“我們對(duì)可穿戴式平臺(tái)的看法，是把它想成像是Google Glass?！?font color="#FFFFFF" >支持原創(chuàng)，鄙視抄襲，請(qǐng)?jiān)L問《國(guó)際電子商情》網(wǎng)站www.zgwwsyw.com

三星首席策略官孫英權(quán)在比利時(shí)IMEC科技論壇介紹Simband 平臺(tái)
8pSesmc

Google也在最近發(fā)布了名為 Android Wear 的可穿戴設(shè)備平臺(tái)，對(duì)此孫英權(quán)表示，三星的Simband不會(huì)特別跟Android綁在一起，會(huì)采用 Tizen 與其他 Linux 變種，包括與英國(guó)軟件開發(fā)商TicTrac合作開發(fā)的一個(gè)版本。 在 三星發(fā)表Simband之前幾天，蘋果(Apple)也才發(fā)表了針對(duì)其iOS 8平臺(tái)的HealthKit與HomeKit──醫(yī)療與家庭自動(dòng)化應(yīng)用程序編程接口(API)；蘋果新發(fā)表的API呼應(yīng)了Webkit開放源碼軟件，并利用蘋果現(xiàn)有的Made for iPhone 程序，已獲得包括博通(Broadcom)、賽普拉斯半導(dǎo)體(Cypress)、美滿電子(Marvell)等眾多芯片供貨商與軟件業(yè)者支持。 產(chǎn)業(yè)顧問機(jī)構(gòu)Envisioneering資深分析師Richard Doherty表示，三星或許在推動(dòng)醫(yī)療革命上的腳步稍稍遲了一點(diǎn)，但其大動(dòng)作有可能吸引更多追隨者：“三星能利用其半導(dǎo)體與制造方面的能力，提供非常有力的生物醫(yī)療傳感器數(shù)組，顯著降低進(jìn)入該市場(chǎng)的門坎?！? 而孫英權(quán)本人也不是省油的燈，他擁有電子電機(jī)工程背景、并在麻省理工 學(xué)院(MIT)取得MBA學(xué)位，曾在英特爾(Intel)工作十年，隨后并曾在安捷倫(Agilent)等公司任職；他曾擔(dān)任ARM、Cadence、 Cymer等公司董事會(huì)成員，以及新創(chuàng)公司Inphi執(zhí)行長(zhǎng)，現(xiàn)在則是在三星扮演救火隊(duì)長(zhǎng)的角色，期望能將這家全球最大的電子廠商之一推向下一個(gè)階段，并 率領(lǐng)公司迎接與蘋果等同業(yè)進(jìn)行的下一場(chǎng)行動(dòng)設(shè)備大戰(zhàn)。 本文授權(quán)編譯自EE Times，版權(quán)所有，謝絕轉(zhuǎn)載 第2頁(yè)：從人體外進(jìn)軍人體內(nèi)，游戲規(guī)則完全不同 第3頁(yè)：將電子產(chǎn)品放到人體？成本可能高達(dá)50億美元

相關(guān)閱讀：
• 分析師預(yù)測(cè)可穿戴設(shè)備市場(chǎng)三種發(fā)展情況
• 制造業(yè)增長(zhǎng)提速，供應(yīng)鏈須配合新一輪發(fā)展
• 家用醫(yī)療保健市場(chǎng)規(guī)模2018年可達(dá)126億美元8pSesmc

{pagination} 推動(dòng)醫(yī)療革命沒那么簡(jiǎn)單 為高通(Qualcomm)建立數(shù)字健康業(yè)務(wù)Qualcomm Life的Donald Jones也期望能推動(dòng)醫(yī)療革命，他策劃過一項(xiàng)總獎(jiǎng)金1,000萬美元的競(jìng)賽，邀請(qǐng)各方好手將科幻影集《星際迷航》（Star Trek）里的三度儀(tricorder)成為現(xiàn)實(shí)；所謂的三度儀是一種可攜式的檢測(cè)與掃描儀器，可用來判別各種生物/無生物的名稱與成分，并進(jìn)行傷員或病人的診斷等等。該設(shè)計(jì)賽的得主將在2016年出爐。 目前Jones擔(dān)任美國(guó)斯克利普斯應(yīng)用科學(xué)研究所(Scripps Translational Science Institute，STSI)的首席數(shù)碼官(chief digital officer)，與眾多主要是新創(chuàng)公司的廠商合作，已經(jīng)打造出類似三度儀的設(shè)備與應(yīng)用程序，能診斷包括糖尿病、心臟病或哮喘等疾病，并以較好的方式來提供病患藥物；他表示，這個(gè)領(lǐng)域已經(jīng)是風(fēng)險(xiǎn)投資業(yè)者眼中成長(zhǎng)最快、也是群眾募資最熱門的項(xiàng)目。 在同一場(chǎng)IMEC科技論壇上，Jones表示：“我們認(rèn)為手表還是比較方便與醫(yī)療設(shè)備互動(dòng)的產(chǎn)品…智能貼片(smart patches)也是一個(gè)能達(dá)到數(shù)十億出貨量的商機(jī)…此外人體則將成為因特網(wǎng)的節(jié)點(diǎn)。”不過他也指出，并非所有人都想看到醫(yī)療革命。 “消費(fèi)者已經(jīng)準(zhǔn)備好了，實(shí)際問題所在是傳統(tǒng)醫(yī)療領(lǐng)域是否已經(jīng)準(zhǔn)備好──但消費(fèi)者還是會(huì)扮演推手?！盝one舉例表示，很多相關(guān)設(shè)備與應(yīng)用程序已經(jīng)吸引了數(shù)百萬使用者：“當(dāng)消費(fèi)者擁有關(guān)于醫(yī)療照護(hù)供應(yīng)者在質(zhì)量、便利性與評(píng)比方面的透明信息，政府單位將必須有所回應(yīng)；但當(dāng)實(shí)際執(zhí)行醫(yī)療的機(jī)構(gòu)界線變得模糊，政府可能也會(huì)遇到麻煩。” 三星孫英權(quán)想推動(dòng)的醫(yī)療革命，也可能會(huì)面臨很大的挑戰(zhàn)。醫(yī)療大廠Johnson & Johnson (J&J)首席科學(xué)官Paul Stoffels在IMEC研討會(huì)后接受EETimes美國(guó)版編輯采訪時(shí)指出：“當(dāng)你從人體外的世界想進(jìn)軍人體內(nèi)的世界，游戲規(guī)則會(huì)完全不同?！彼硎?， 你必須與美國(guó)聯(lián)邦食品暨藥物管理局(FDA)等政府單位打交道，你需要進(jìn)行臨床實(shí)驗(yàn)并證明你的方法是正確的，那可能需要花費(fèi)5~15年，并長(zhǎng)期投資。支持原創(chuàng)，鄙視抄襲，請(qǐng)?jiān)L問《國(guó)際電子商情》網(wǎng)站www.zgwwsyw.com

三星的Simband平臺(tái)包含尺寸14x34mm 的GHz等級(jí)SoC，配備雙ARM Cortex A7核心，支持Wi-Fi與藍(lán)牙
8pSesmc

本文授權(quán)編譯自EE Times，版權(quán)所有，謝絕轉(zhuǎn)載 第3頁(yè)：將電子產(chǎn)品放到人體？成本可能高達(dá)50億美元

相關(guān)閱讀：
• 分析師預(yù)測(cè)可穿戴設(shè)備市場(chǎng)三種發(fā)展情況
• 制造業(yè)增長(zhǎng)提速，供應(yīng)鏈須配合新一輪發(fā)展
• 家用醫(yī)療保健市場(chǎng)規(guī)模2018年可達(dá)126億美元8pSesmc

{pagination} 消費(fèi)性電子產(chǎn)業(yè)與醫(yī)療產(chǎn)業(yè)必須相互學(xué)習(xí)，討論如何將電子產(chǎn)品放到人體；這不是個(gè)簡(jiǎn)單任務(wù)，成本可能高達(dá)50億美元，而相關(guān)法規(guī)以及商業(yè)付款機(jī)制都得有所改 變。Stoffels依據(jù)其經(jīng)驗(yàn)表示：“在我們的世界，要推出一項(xiàng)新產(chǎn)品往往要投資30億至50億美元，但有可能在上市前一個(gè)星期宣告失敗?！彼?出，J&J每年花費(fèi)近20億美元在臨床實(shí)驗(yàn)上。支持原創(chuàng)，鄙視抄襲，請(qǐng)?jiān)L問《國(guó)際電子商情》網(wǎng)站www.zgwwsyw.com “我曾在數(shù)年前申請(qǐng)生物醫(yī)療感測(cè)系統(tǒng)的專利；”Envisioneering的Doherty表示：“要與FDA以及眾多海外國(guó)家的政府機(jī)構(gòu)交涉，所需要的技 巧與我所受的科學(xué)與工程訓(xùn)練完全無關(guān)?！彼硎?，要搞定所有政府相關(guān)機(jī)構(gòu)，會(huì)是群眾募資網(wǎng)站上的小型新創(chuàng)公司到大廠如三星所共同面臨的障礙：“包括 Philips、GE與Siemens等公司都聘請(qǐng)大批對(duì)技術(shù)專精的專人，只負(fù)責(zé)與那些政府機(jī)構(gòu)交涉。” STSI的Jones指出，推動(dòng)醫(yī)療革命需要獨(dú)門武器。如新創(chuàng)公司Scanadu已經(jīng)開始在募資網(wǎng)站Indegogo預(yù)售一款可量測(cè)心律、血壓、心跳的小型設(shè)備，并要求預(yù)購(gòu)者同意成為臨床實(shí)驗(yàn)者；截至目前為止，該款設(shè)備已經(jīng)募集到1,340萬美元，打破該募資網(wǎng)站的最高紀(jì)錄。 此 外隱私權(quán)也會(huì)是一大挑戰(zhàn)；Envisioneering的Doherty指出：“消費(fèi)者對(duì)廠商的信任一旦破滅，就永遠(yuǎn)難以恢復(fù)?！倍捎谛乱淮尼t(yī)療設(shè)備 與服務(wù)是透過無線網(wǎng)絡(luò)運(yùn)作，使得情況更為復(fù)雜：“所有無線傳輸?shù)男畔?shí)際上都有可能被攔截或是被干擾，此外醫(yī)療院所對(duì)于無線信號(hào)傳輸也會(huì)有比較嚴(yán)格的限 制?！? 對(duì)此三星的孫英權(quán)表示，該公司計(jì)劃建立一個(gè)儲(chǔ)存并保護(hù)個(gè)人醫(yī)療信息的數(shù)據(jù)庫(kù)，消費(fèi)者能讀取并決定與誰分享其中的訊息?！澳隳軐?duì)你自己的生物信息負(fù)責(zé)；”這個(gè)承諾再次強(qiáng)調(diào)了他與其他眾多數(shù)字醫(yī)療供貨商所描述的醫(yī)療革命愿景。 本文授權(quán)編譯自EE Times，版權(quán)所有，謝絕轉(zhuǎn)載 編譯：Judith Cheng 參考英文原文：Samsung Joins Medical Revolution，by Rick Merritt

相關(guān)閱讀：
• 分析師預(yù)測(cè)可穿戴設(shè)備市場(chǎng)三種發(fā)展情況
• 制造業(yè)增長(zhǎng)提速，供應(yīng)鏈須配合新一輪發(fā)展
• 家用醫(yī)療保健市場(chǎng)規(guī)模2018年可達(dá)126億美元8pSesmc

{pagination} Samsung Joins Medical Revolution Rick Merritt BRUSSELS – Young Sohn has joined the digital medical revolution. He is building a platform for devices and apps that let consumers manage their fitness and ultimately, he hopes, their healthcare. Many others are trying to create this revolution, but few are as high profile as the chief strategy officer of Samsung Electronics. They too want to create bracelets and watches and smartphones and apps that disrupt today's medical establishment. At a developer conference in San Francisco this fall Sohn will publish hardware interfaces for Simband, an open specification for a bracelet that can accommodate a wide array of fitness and medical sensors. At the event he also will release software interfaces for writing programs and cloud services for the platform. An alpha version of the Simband is already in the hands of about ten developers, mainly startup companies. Sohn is also courting giants such as sensor maker Bosch whom he planned to visit on a swing through Europe. "This whole area is in a very early stage and many startups need a platform, so our goal is to have 50-100 companies that plug into these interfaces," said Sohn in an interview at the annual Imec Tech Forum here. Samsung will ship its own beta products at the fall event and anticipates commercial versions next year. It also aims to spend $50 million of its venture funds on startups who develop sensors or software for its platform. So far it has announced two partnerships. The University of San Francisco will help validate its sensors, presumably at its medical school facilities. The Imec research institute is the first announced partner with a sensor, a multifunction device that measures electrocardiograms, bio-impedance, skin temperature, acceleration, and more. "Think of it as Google Glass, our view of a wearable platform," said Sohn. Young Sohn talks about his Simband initiative at the Imec Tech Forum in Brussels. Of course, Google already has its own recently announced platform called Android Wear. Sohn says Simband is not specifically tied to Android but will use Tizen and other mobile Linux variants including one developed by a software partner in England called TicTrac. Samsung formally launched its initiative just days before Apple launched HealthKit and HomeKit, medical and home automation APIs in its iOS version 8. The APIs echo the name of the open-source WebKit software and leverage Apple's existing Made for iPhone program, supported by chip and software companies including Broadcom, Cypress, Marvell, and many others. Samsung may be a bit late to the revolution but it brings big guns and will attract followers, said veteran technology analyst Richard Doherty, principal of Envisioneering (Seaford, N.Y.). "Samsung has clearly lowered the bar to entry by using its semiconductor and manufacturing clout to deliver a very powerful biomedical sensor array," Doherty said. Sohn has his personal chops, too. The EE earned an MBA at MIT, then spent ten years at Intel before rising to lead a string of companies including Agilent. He served on the boards of ARM, Cadence, and Cymer and was brought in as CEO to take startup Inphi Corp. public. Now he is taking his corporate firefighter role to the next level at the world's largest electronics company, helping lead an important next stage of its mobile battle with Apple and others. Next page: To the tricorder and beyond To the tricorder and beyond Donald Jones also wants to drive this revolution. While helping Qualcomm establish its digital health group, he created a $10 million competition to see who could create a real tricorder, the fictional gadget used to diagnose and treat everything from illnesses to gunshots in the TV series Star Trek. Winners will be picked in 2016. Now as the chief digital officer of the Scripps Translational Science Institute, Jones works with dozens of mainly startup companies already making tricorder-like gadgets or apps for treating diseases such as diabetes or heart disease or asthma or for simply delivering medications in a better way. The sector has become the fastest growing area for venture capitalists and a magnet for crowdsourcing, Jones said. "We think watches will be a convenient way to interact with medical devices... smart patches are a billion-plus unit opportunity... [and] bodies will be nodes on the Internet," Jones said in a presentation at the Imec event. Not everyone wants a revolution in medicine. "Consumers are ready, the real question is whether traditional medicine is ready -- but consumers will push it over the top," Jones said, giving examples of gadgets and apps already attracting millions of users. Viva la revolution: A sampler of digital medical trials at Scripps. "When the consumer has transparent information about quality, convenience and ratings for health care providers, governments will have to start responding," he said. But "borders around practicing medicine will blur, and governments will have trouble with it," he predicted. Next page: Regulatory and security challenges Regulatory and security challenges The medical revolutionaries like Young Sohn face big challenges. "When you go from working outside to inside the body, it’s a totally different game," said Paul Stoffels, chief scientific officer at healthcare giant Johnson & Johnson, responding to a question from EE Times after a talk at the Imec event. You start needing to work with the U.S. FDA and other regulatory agencies. You need to do clinical trials and prove you are right. It takes 5-15 years with long term investments. The [consumer and medical] industries will have to learn from each other about how to bring electronics to the body. It's not an easy thing. It can cost $5 billion. The regulatory and payment environment has to change. Stoffels knows from experience. "In our world, we invest three to five billion dollars on a new product that can fail a week before a planned launch," he said, noting J&J spends nearly $2 billion annually on clinical trials. "I patented several biomedical sensor systems years ago," said analyst Doherty. "Dealing with the FDA and many overseas regulators is very different than anything my science and engineering training prepared me for," he said. Handling regulators is likely to be a hurdle for every medical wannabe from the smallest Kickstarter startup to consumer giants such as Samsung. "Philips, GE and Siemens employ large contingents of tech-savvy people just to interface with those agencies," said Doherty. Jones notes the medical revolutionaries have some unique weapons. Startup Scanadu pre-sold its device on Indegogo and with each sale customers had to agree to be part of a clinical trial. The $1.34 million it raised broke the record for the crowdsourcing site. Samsung's Simband includes a 14x34mm GHz-class SoC with two ARM Cortex A7 cores, Wi-Fi and Bluetooth. Privacy is the other big challenge. "Trust is there until broken, and once broken is never the same again," said analyst Doherty. The problem is compounded by the fact the new gadgets and services run on wireless networks. "Anything wireless is also open for signal interception or interference," said Doherty. "Also, clinics and hospitals have strict RF signaling rules," he added. For his part, Sohn compares Samsung's planned services to a bank that stores and secures personal medical data that consumer can access and share whenever they like with whomever they want. "You can be responsible for your bioinformatics," says Sohn, repeating one of the big promises he and many other digital medical entrepreneurs say will come with the revolution.